The Prevention of Breast Cancer: An Overview

References

• Pisani, P., Parkin, D. M., Bray, F. and Ferlay, J. (1999). Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer, 83, 18–29.
   PubMed Web of Science ®Google Scholar
• McTiernan, A. (2000). Associations between energy balance and body mass index and risk of breast carcinoma in women from diverse racial and ethnic backgrounds in the U.S. Cancer, 88, 1248–1255.
   PubMed Web of Science ®Google Scholar
• Stoll, B. A. (2000). Adiposity as a risk determinant for postmenopausal breast cancer. Int. J. Obes. Relat. Metab. Disord., 24, 527–533.
   PubMed Web of Science ®Google Scholar
• Freedman, L., Clifford, C. and Messina, M. (1990). Analysis of dietary fat, calories, body weight and the development of mammary tumours in rats and mice: a review. Cancer Res., 50, 5710–5719.
   PubMed Web of Science ®Google Scholar
• Wu, A. H., Pike, M. C. and Stram, D. O. (1999). Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer. J. Natl. Cancer Inst., 91, 529–534.
   PubMed Web of Science ®Google Scholar
• Willett, W. C. (1999). Dietary fat and breast cancer. Toxicol. Sci., 52, 127–146.
   PubMed Web of Science ®Google Scholar
• Hilakivi-Clarke, L., Onojafe, I., Raygada, M., Cho, E., Skaar, T., Russo, I. and Clarke, R. (1999). Prepubertal exposure to zearalenone or genistein reduces mammary tumori-genesis. Br. J. Cancer, 80, 1682–1688.
   PubMed Web of Science ®Google Scholar
• Constantinou, A. I., Krygier, A. E and Mehta, R. R. (1998). Genistein induces maturation of cultured human breast cancer cells and prevents tumour growth in nude mice. Am. J. Clin. Nutrition, 68, 1426S–1430S.
   PubMed Web of Science ®Google Scholar
• Key, T. J., Sharp, G. B., Appleby, P. N., Beral V., Goodman, M. T., Soda, M. and Mabuchi K. Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan. Br. J. Cancer, 81, 1248-1256.
   Google Scholar
• Gertig, D. M., Hankinson, S. E., Hough, H., Spiegelman, D., Colditz, G. A., Willett, W. C., Kelsey, K. T. and Hunter, D. J. (1999). N-acetyl transferase 2 genotypes, meat intake and breast cancer risk. Int. J. Cancer, 80, 13–17.
   PubMed Web of Science ®Google Scholar
• Deitz, A. C., Zheng, W., Leff, M. A., Gross, M., Wen, W. Q., Doll, M. A., Xiao, G. H., Folsom, A. R. and HeM, D. W., (2000). N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women. Cancer Epidemiol. Biomark. Prey., 9, 905–910.
   PubMed Web of Science ®Google Scholar
• Key, T. J., Fraser, G. E., Thorogood, M., Appleby, P. N., Beral, V., Reeves, G., Burr,M. L., Chang-Claude, J., Frentzel-Beyme, R., Kuzma, J. W., Mann, J. and McPherson, K. (1999). Mortality in vegetarians and nonvegetarians: detailed findings from a collaborative analysis of 5 prospective studies. Am. J. Clin. Nutr, 70, 516S–524S.
   PubMed Web of Science ®Google Scholar
• Rohan, T. E., Jain, M., Howe, G. R. and Miller, A. B. (2000). Alcohol consumption and risk of breast cancer: a cohort study. Cancer Causes Control, 11, 239–247.
   PubMed Web of Science ®Google Scholar
• Kuper, H., Ye, W., Weiderpass, E., Ekbom, A., Trichopoulos, D., Nyren, 0. and Adami, H. 0. (2000). Alcohol and breast cancer risk: the alcoholism paradox. Br. J. Cancer, 83, 949–951.
   Google Scholar
• Wu, K., Helzlsouer, K. J., Comstock, G. W., Hoffman, S. C., Nadeau. M. R. and Selhub, J. (1999). A prospective study on folate, B12, and pyridoxal 5'-phosphate (B6) and breast cancer. Cancer Epidemiol. Biomark. Prey., 8, 209–217.
   PubMed Web of Science ®Google Scholar
• Stoll, B. A. (1999). Western nutrition and the insulin resistance syndrome: a link to breast cancer. Eur. J. Clin.Nutr., 53, 83–87.
   PubMed Web of Science ®Google Scholar
• Veronesi, U., DePalo, G., Marubini, E., Costa, A., Mariani, L., Formelli, F. and Decensi, A. (1999). Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. J. Natl. Cancer Inst., 91, 1847–1856.
   PubMed Web of Science ®Google Scholar
• Collaborative Group on Hormonal Factors in Breast Cancer (1996). Breast cancer and hormonal contraceptives: further results. Contraception, 54, 1S–106S.
   PubMed Web of Science ®Google Scholar
• Collaborative Group on Hormonal Factors in Breast Cancer (1997). Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet, 350, 1047–1059.
   PubMed Web of Science ®Google Scholar
• Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M. and Cronin, W. M. (1998). Tamoxifen for the prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl. Cancer Inst., 90, 1371–1388.
   PubMed Web of Science ®Google Scholar
• Veronesi, U., Maisonneuve, P., Costa, A., Sacchini, V., Maltoni, C. and Robertson, C. (1998). Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterec-tomised women. Italian Tamoxifen Prevention Study. Lancet, 352, 93–97.
   PubMed Web of Science ®Google Scholar
• Powles, T., Eeles, R., Ashley, S., Easton, D., Chang, J. and Dowsett, M. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet, 352, 98–101.
   PubMed Web of Science ®Google Scholar
• Rebbeck, T. R., Levin, A. M., Eisen, A., Snyder, C., Watson, P. and Cannon-Albright, L. (1999). Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J. Natl. Cancer Inst., 91, 1475–1479.
   Google Scholar
• Cummings, S. R., Eckert, S., Krueger, K., Grady, D., Powles, T. J. and Cauley, J. A. (1999). The effect of raloxifene on the risk of breast cancer in postmenopausal women: results from the MORE randomized trial. JAMA, 281, 2189–2197.
   PubMed Web of Science ®Google Scholar
• Cauley, J., Krueger, K., Eckert, S., Cummings, S. R., Grady, D and Powles, T. J. (2000). Breast cancer risk in post-meno-pausal women with osteoporosis is reduced with raloxifene treatment: Extension of the MORE trial data to a median follow up of 48 months. Proc. Am. Soc. Clin. Oncol., 88a, Abstract No. 356.
   Google Scholar
• Hwang, D., Scollard, D., Byrne, J. and Levine, E. (1998). Expression of cyclooxegenase-1 and cyclooxygenase-2 in human breast cancer. J. Natl. Cancer Inst., 90, 455–460.
   PubMed Web of Science ®Google Scholar
• Harris, R. E., Kasbari, S. and Farrar, W. B. (1999). Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer. Oncol. Rep., 6, 71–73.
   PubMed Web of Science ®Google Scholar
• Harris, R. E., Alshafi, G. A., Abou-Issa, H. and Seibert, K. (2000). Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor. Cancer Res., 60, 2101–2103.
   PubMed Web of Science ®Google Scholar
• Hartmann, L. C., Schaid, D. J., Woods, J. E.,Crotty, T. P., Myers, J. L. and Arnold, P. G. (1999). Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N. Engl. J. Med., 340, 77–84.
   PubMed Web of Science ®Google Scholar
• Hartmann, L. C., Schaid, D. J. and McDonnell, S. K. (2000). Contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. Proc. Am. Soc. Clin. Oncol., 77a, Abstract No. 298.
   Google Scholar